Celltrion, Inc.

ISIN KR7068270008

 | 

WKN A0RM6K

Market cap (in EUR)
27,382 m
Country
South Korea
Sector
Healthcare
Dividend yield
0.36%
 

Overview

Description

Celltrion, Inc. engages in the development, production, and sale of antibody drugs for the treatment of cancer and autoimmune diseases. It operates through the Biopharmaceuticals, Chemical Drugs, and Others businesses. Its products include Remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals South Korea

Financials

Key metrics

Market capitalisation, EUR 27,382 m
EPS, EUR 2.94
P/B ratio 2.6
P/E ratio 44.1
Dividend yield 0.36%

Income statement (2025)

Revenue, EUR 2,597 m
Net income, EUR 642 m
Profit margin 24.74%

What ETF is Celltrion, Inc. in?

There are 27 ETFs which contain Celltrion, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Celltrion, Inc. is the iShares MSCI Emerging Markets Islamic UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI AC Far East ex-Japan UCITS ETF 0.29%
Equity
Asia Pacific
1,136
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.01%
Equity
World
Multi-Asset Strategy
914
Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing 0.50%
Equity
Asia Pacific
1,812
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
14
iShares MSCI EM UCITS ETF (Dist) 0.22%
Equity
Emerging Markets
7,392
UBS Core MSCI EM UCITS ETF USD dis 0.21%
Equity
Emerging Markets
2,004
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
712
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.03%
Equity
World
30,518
JPMorgan AC Asia Pacific ex Japan Research Enhanced Index Equity (ESG) UCITS ETF USD (dist) 0.04%
Equity
Asia Pacific
Social/Environmental
0
Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF (USD) Accumulating 0.50%
Equity
Asia Pacific
606
Vanguard FTSE Developed World UCITS ETF Acc 0.03%
Equity
World
4,836
iShares MSCI Emerging Markets Islamic UCITS ETF 0.61%
Equity
Emerging Markets
Islamic Investing
414
JPMorgan Global Emerging Markets Research Enhanced Index Equity (ESG) UCITS ETF USD (dist) 0.05%
Equity
Emerging Markets
Social/Environmental
24
JPMorgan All Country Research Enhanced Index Equity Active UCITS ETF USD (dist) 0.01%
Equity
World
Social/Environmental
50
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
36
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.03%
Equity
World
18,603
iShares MSCI ACWI UCITS ETF USD (Acc) 0.03%
Equity
World
22,148
Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing 0.25%
Equity
Asia Pacific
Social/Environmental
35
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
68
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
204
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.03%
Equity
World
Social/Environmental
454
iShares MSCI EM IMI Screened UCITS ETF USD (Dist) 0.19%
Equity
Emerging Markets
Social/Environmental
1,162
iShares MSCI EM ESG Enhanced CTB UCITS ETF USD (Dist) 0.06%
Equity
Emerging Markets
Social/Environmental
1,070
Vanguard FTSE Developed World UCITS ETF Distributing 0.03%
Equity
World
3,366
Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist 0.22%
Equity
Emerging Markets
897
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
90
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
93
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.